Quick Answer
Twist Bioscience Corp reported Long-Term Debt of $1.40 million for fiscal year 2020.
Twist Bioscience Corp Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2020 | $1.40M | -68.1% |
| 2019 | $4.40M | -39.0% |
| 2018 | $7.22M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| December 31, 2020 | $625.0K | -83.0% | -55.5% |
| September 30, 2020 | $1.40M | -68.1% | -35.3% |
| June 30, 2020 | $2.17M | -57.6% | -25.8% |
| March 31, 2020 | $2.92M | -49.8% | -20.3% |
| December 31, 2019 | $3.67M | -43.8% | -16.6% |
| September 30, 2019 | $4.40M | -39.0% | -14.0% |
| June 30, 2019 | $5.12M | — | -12.2% |
| March 31, 2019 | $5.83M | — | -10.7% |
- Twist Bioscience Corp showed a decrease of -68.1% in Long-Term Debt compared to the prior fiscal year.
- Over the 2018–2020 period, Twist Bioscience Corp’s long-term debt has declined by 80.6% (from $7.22 million to $1.40 million).
- The most recent figure is from Twist Bioscience Corp’s fiscal year 2021 report (Form 10-K), filed with the SEC on November 23, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: